Physician profile
Christopher Pugh
NPI 1972535698
$2,411.79
in general payments reported to CMS, 2019-2025
21 companies · $49.11 in 2025
The $49.11 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,749 · 2020: $539 · 2021: $17.27 · 2023: $30.85 · 2024: $26.73 · 2025: $49.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.69 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.69 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $423.74 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.47 | 2019-2020 | |
| Genentech USA, INC. | $290.27 | 2019-2020 | |
| Glaxosmithkline, LLC. | $275.42 | 2019-2024 | Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $243.32 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $153.46 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $133.29 | 2019 | |
| Genzyme Corporation | $130.80 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $91.23 | 2019-2020 | |
| Grifols USA, LLC | $66.49 | 2019-2020 | |
| Insmed, INC. | $40.52 | 2019-2025 | Arikayce |
| Mylan Specialty L.P. | $36.46 | 2019-2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Inspire Medical Systems, INC. | $30.85 | 2023 | Inspire |
| Philips North America LLC | $28.94 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breathe Technologies, INC. | $21.50 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.29 | 2019 | |
| Allergan, INC. | $15.79 | 2019 | |
| Shire North American Group INC | $14.65 | 2019 | |
| Merck Sharp & Dohme LLC | $12.80 | 2019 | |
| United Therapeutics Corporation | $2.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.